-
A Strategy to Reduce Cardiovascular Disease by More Than 80 Percent;
Pearly Penile Papules: Still No Reason for Uneasiness; The Epidemiology
of Major Depressive Disorder; Urinary Tetrahydroaldosterone as a Screen
for Aldosteronism; Finasteride and Prostate Cancer; Impermeable Bed
Covers in Patients with Allergic Rhinitis
-
The FDA has approved vardenafil (LevitraBayer and GlaxoSmithKline) for the treatment of erectile dysfunction in men.
-
Several excellent reviews have considered the advantages and disadvantages of popular diets, including those that feature dietary protein, but none has focused exclusively on a sample of best-seller diets, as enjoyed by the public. This article analyzes the claims of, scientific evidence for, and sustainability of 6 popular bestseller diets, along with their published recipes.
-
-
A generic form of paroxetine (PaxilGlaxoSmithKline) will soon be on the market. The drug marks the second SSRI antidepressant to go generic after fluoxetine (Prozac) last year.
-
Insulin Plus Metformin vs Triple Oral Therapy in Type 2 Diabetes; ARB
and ACE-I in Diabetic Nephropathy; Low-Glycemic Index Diets and
Diabetes; Ultralow-Dose Estrogen and Bone in Older Women; Effect of
Intensity of Oral Anticoagulation in Atrial Fibrillation; Patient
Knowledge and Awareness of Hypertension
-
-
Infertility is a common condition and usually presents to the primary care physician initially. Infertility is defined as 1 year of unprotected intercourse in which a pregnancy has not been achieved. Fifteen to twenty percent of couples in the United States are infertile, and this rate has remained relatively stable since the early 1980s.
-
The FDA has approved Pfizer's eplerenone (Inspra) for the treatment of congestive heart failure (CHF) in patients who have sustained a myocardial infarction.
-